Drug Channels Institute (DCI) is a leading source of industry research about pharmaceutical economics and the drug distribution system. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View a sample of our modules

View Sample

Industry Reports

The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >

The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >

From The Drug Channels Blog

Wednesday, May 20, 2026

PBM Shakeout: How Vertical Integration Is Reshaping What’s Next (VIDEO)

Here at Drug Channels, we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) industry for many years. The short video below—excerpted from DCI’s recent more >

Friday, May 15, 2026

Protecting Gross-to-Net Performance Through Single-Channel Ecosystems

Today’s guest post comes from Peter Darch, SVP of Strategy and Operations at PHIL Inc. Peter explains that growing pressure on drug pricing is exposing structural inefficiencies in gross-to-net more >